| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 324 |
| 1 | TACROLIMUS | 284 |
| 2 | PREDNISOLONE | 264 |
| 3 | PREDNISONE | 264 |
| 4 | TACROLIMUS CAPSULES | 258 |
| 5 | VALGANCICLOVIR | 157 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 157 |
| 7 | METHYLPREDNISOLONE | 148 |
| 8 | INFLIXIMAB | 134 |
| 9 | GANCICLOVIR SODIUM | 131 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERRIC MALTOL | 1 | 0.0556 |
| 1 | BRINCIDOFOVIR | 4 | 0.0506 |
| 2 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0222 |
| 3 | INFLIXIMAB-AXXQ | 2 | 0.0204 |
| 4 | CIDOFOVIR ANHYDROUS | 18 | 0.0200 |
| 5 | GANCICLOVIR SODIUM | 131 | 0.0187 |
| 6 | FOSCARNET SODIUM | 40 | 0.0149 |
| 7 | VALGANCICLOVIR | 157 | 0.0135 |
| 8 | SHARK CARTILAGE | 1 | 0.0132 |
| 9 | CLOCORTOLONE PIVALATE | 1 | 0.0128 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 678 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 188 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 168 |
| 3 | Alkylating Drug [EPC] | 154 |
| 4 | Nucleoside Analog Antiviral [EPC] | 124 |
| 5 | Purine Antimetabolite [EPC] | 118 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 111 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 103 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 94 |
| 9 | Kinase Inhibitor [EPC] | 84 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0182 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 188 | 0.0145 |
| 2 | Human Immunoglobulin [EPC] | 1 | 0.0130 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 10 | 0.0092 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 20 | 0.0072 |
| 5 | Interleukin-2 Receptor Blocking Antibody [EPC] | 54 | 0.0069 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 40 | 0.0046 |
| 7 | Immunoglobulin G [EPC] | 25 | 0.0042 |
| 8 | CD30-directed Immunoconjugate [EPC] | 17 | 0.0030 |
| 9 | Purine Antimetabolite [EPC] | 118 | 0.0019 |